Diabetology & Metabolic Syndrome

Table 3 Bone mineral density (BMD) of the lumbar spine, femoral neck and total hip

From: Vildagliptin has the same safety profile as a sulfonylurea on bone metabolism and bone mineral density in post-menopausal women with type 2 diabetes: a randomized controlled trial

	Vildagliptin N = 19		Gliclazide MR N = 18		p value
	Mean	Standard deviation	Mean	Standard deviation
BMD of the lumbar spine (g/cm²)
Baseline	0.956	0.212	0.972	0.121	0.771
Month 12	0.956	0.211	0.964	0.118	0.880
Difference from baseline	0.000	0.025	−0.008	0.036	0.434
BMD of the femoral neck (g/cm²)
Baseline	0.777	0.161	0.791	0.092	0.747
Month 12	0.781	0.172	0.801	0.116	0.659
Difference from baseline	0.004	0.055	0.011	0.033	0.612
BMD of the total hip (g/cm²)
Baseline	0.923	0.144	0.934	0.108	0.789
Month 12	0.921	0.154	0.935	0.113	0.743
Difference from baseline	−0.002	0.029	0.002	0.023	0.648

Back to article page

ISSN: 1758-5996

Contact us

Submission enquiries: journalsubmissions@springernature.com